UDP- N -acetylglucosamine: galactose-β1,3- N...

Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S006120

Reexamination Certificate

active

07094887

ABSTRACT:
A novel gene defining a novel human UDP-GlcNAc: Galβ1-3GalNAcα β1,6GlcNAc-transferase, termed C2GnT3, with unique enzymatic properties is disclosed. The enzymatic activity of C2GnT3 is shown to be distinct from that of previously identified enzymes of this gene family. The invention discloses isolated DNA molecules and DNA constructs encoding C2GnT3 and derivatives thereof by way of amino acid deletion, substitution or insertion exhibiting C2GnT3 activity, as well as cloning and expression vectors including such DNA, cells transfected with the vectors, and recombinant methods for providing C2GnT3. The enzyme C2GnT3 and C2GnT3-active derivatives thereof are disclosed, in particular soluble derivatives comprising the catalytically active domain of C2GnT3. Further, the invention discloses methods of obtaining 1,6-N-acetylglucosaminyl glycosylated saccharides, glycopeptides or glycoproteins by use of an enzymically active C2GnT3 protein or fusion protein thereof or by using cells stably transfected with a vector including DNA encoding an enzymatically active C2GnT3 protein as an expression system for recombinant production of such glycopeptides or glycoproteins. Methods are disclosed for the identification of agents with the ability to inhibit or stimulate the biological activity of C2GnT3. Furthermore, methods of using C2GnT3 in the structure-based design of inhibitors or stimulators thereof are also disclosed in the invention. Also a method for the identification of DNA sequence variations in the C2GnT3 gene by isolating DNA from a patient, amplifying C2GnT3-coding exons by PCR, and detecting the presence of DNA sequence variation, are disclosed.

REFERENCES:
patent: 5766910 (1998-06-01), Fukuda et al.
patent: 6136580 (2000-10-01), Fukuda et al.
patent: 6593119 (2003-07-01), Korczak et al.
patent: WO 90/07000 (1989-11-01), None
patent: WO 94/07917 (1994-04-01), None
Broun et al., Science, 282, 1315-1317, 1998.
Seffernick et al., J. Bacteriol., 183(8), 2405-2410, 2001.
Adams et al., EST database, Accession No. AQ005888, 1998.
Almeida et al., Glycoconjugate J. 1997, 14:S44.
Almeida et al., Journ. of Biol. Chem., 1997; 272(51):31979-31991.
Altschul et al., J. Mol. Biol., 1990; 215:403-410.
Asano, M. et al. EMBO J. 16:1850-1857, 1997.
Axford, J.S. et al., Autoimmunity 17:157-163, 1994.
Baum et al., J. Exp. Med., 1995; 181:877-887.
Bennett et al., Journ. of Biol. Chem., 1996; 271(29):17006-17012.
Bierhuizen et al., Glycobiology, 1995; 5(4):417-425.
Bierhuizen et al., Proc. Natl. Acad. Sci. USA, 1992; 89:9326-9330.
Breathnach, R. et al.., Ann. Rev. Biochem. 50:349-83, 1981.
Brew, K. et al., Biochemistry 59:491-97, 1968.
Brockhausen et al., Eur. J. Biochem., 1995; 233:607-617.
Brockhausen et al., Cancer Research, 1991; 51:1257-1263.
Clausen et al., Glycobiology, 1996; 6(6):635-646.
D'Agostaro, G. et al., Eur. J. Biochem. 183:211-217, 1989.
Devereux et al., Nucleic Acids Research, 1984; 12(1).
Fujita-Yamaguchi, Y. et al., J. Biol. Chem. 256:(6):2701-2706, Mar. 25, 1981.
Fukuda, Cancer Research, 1996; 56:2237-2244.
Furukawa, K. et al., Inter. Immunology 2(1):105-112, 1990.
Gentzsch, M. and Tanner, W. (1996) EMBO J., 15:5752-5759.
Higgin, G., et al., J. Biol. Chem., 1991; 266(10):6280-6290.
Hollis, G.F. et al., Biophys Res Comm. 162:1069-1075, 1989.
Johnston, D. et al. (1998) J. Biol. Chem. 273(4):1888-1895.
Keusch, J., et al., Glycobiology 5:365-700, 1995.
Kobata, A. Eur J. Biochem. 209:483-501, 1992.
Kozak, M., Ann Rev Cell Biol. 8:197-225, 1992.
Kumar et al., Blood, 1996; 88(10):3872-3879.
Lo et al., Glycobiology (1998), 8:517-526.
Lu, Q., et al.,Develop Biol. 18:257-267, 1997.
Mahairas et al., EST Database, Accession No. AQ091453, Aug. 1998.
Malissard, M., et al., (1996) Eur J. Biochem. 239:340-348.
Masri, K.A., et al., (1988) Biochem Res Comm. 157:657-663.
Matteucci et al., J. Am. Chem. Soc., 1981; 103:3185-3191.
Mengle-Gaw, L., et al., (1985) Biophys Res Comm. 176:1269-1276.
Moscarello M.A., et al., (1991) Biochim Biophys Acta. 831:192-200.
Nakazawa, K. et al. (1988) J. Biochem. 104:165-168.
Nakazawa K. et al. (1991) Eur J. Biochem. 196:363-368.
Narimatsu, H. et al. (1986) Proc Natl Acad Sci USA. 83:4720-4724.
Parquet, M.R. et al., (1984) Biochem J. 218:745-751.
Perillo et al., J. Mol. Med., 1998; 76:402-412.
Perillo et al., Nature, 1995; 378:736-739.
Piller et al., Journ. of Biol. Chem., 1988; 263(29):15146-15150.
Powell, J.T. and Brew, K. (1974) Eur J. Biochem. 48:217-228.
Saitoh et al., Blood, 1991; 77(7):1491-1499.
Sato, T. et al., (1988) Biochem & Biophysical Res. Comm. 244(3):637-641.
Schwientek et al., Journ. of Biol. Chem., 2000; 275(15):11106-11113.
Schwientek et al., Journ. of Biol. Chem., 1999; 274(8):4504-4512.
Shaper, J.H. et al. (1995) Glycoconjugate J. 12:477.
Shaper, N.L. et al. (1986) Proc Nat'l Acad Sci USA. 83:1573-1577.
Shaper, N.L. et al. (1988) J. Biol. Chem. 263:10420-10428.
Shaper, N.L. et al. (1997) J. Biol. Chem. 272:31389-31399.
Sheares, B.T. and Carlson, D. (1984) J. Biol. Chem. 259:8045-8047.
Shur, B.D. (1982) J. Biol. Chem. 257:6871-6878.
Springer, Science, 1984; 224:1198-1206.
Sutherlin, Marie E. et al., (1997) Cancer Research, 57:4744-4748.
Uehara, K. and Muramatsu, T. (1997) Eur. J. Biochem., 244:706-712.
VanDie, I. et al. (1997) Glycobiology, Letter to the Glyco-Forum, pp. v-vii.
Wandall et al., Journ. of Biol. Chem., 1997; 272(38):23503-23514.
Williams et al., Journ. of Biol. Chem., 1980; 255(23):11247-11252.
Wilson, I.B. et al. (1993) J. Rheumatol. 20:1282-1287.
Yang et al., Glycobiology, 1994; 4(6):873-884.
Yeh et al., Journ. of Biol. Chem., 1999; 274(5):3215-3221.
Yoo et al., Journ. of Biol. Chem., 1989; 264(29):17078-17083.
Yousefi et al., Journ. of Biol. Chem., 1991; 266(3):1772-1782.
Yang, Ji-Mao et al. Glycobiology 4:(6)873-884, 1994.
U.S. Appl. No. 60/425,204.
U.S. Appl. No. 10/292,896.
U.S. Appl. No. 09/118,464.
U.S. Appl. No. 10/132,652.
U.S. Appl. No. 09/874,390.
U.S. Appl. No. 09/645,192.
U.S. Appl. No. 10/084,406.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

UDP- N -acetylglucosamine: galactose-β1,3- N... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with UDP- N -acetylglucosamine: galactose-β1,3- N..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and UDP- N -acetylglucosamine: galactose-β1,3- N... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3622127

All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.